Biorevitalisation Patient Selection and Realistic Outcomes
Skin booster treatments have one of the highest patient satisfaction rates in aesthetic medicine — when the right patient is treated, with the right product, and with appropriate outcome expectations established at consultation. They also have one of the most predictable routes to patient dissatisfaction: treating a patient whose concern is structural volume loss with a treatment that addresses skin quality, or promising 'glowing, radiant skin' to a patient whose primary visible concern is a fat hernation or significant volume deficit that biorevitalisation cannot address.
Skin Boosters vs Dermal Fillers: Understanding the Clinical Difference
Skin boosters and dermal fillers are both injectable HA products. They are often displayed side by side in clinic price lists, administered by the same practitioners, and occasionally confused by patients — and even, more problematically, by practitioners — as interchangeable treatments. They are not.
Skin Boosters: The Complete Practitioner's Guide to Biorevitalisation Injectables
Skin boosters have become one of the most searched and most requested injectable treatments in UK and European aesthetics — and one of the most misunderstood. The term is used loosely across the industry to describe a broad category of hydration-focused injectables that range from simple low-viscosity hyaluronic acid preparations to complex formulations combining HA with polynucleotides, amino acids, and growth factors. The clinical results, techniques, and patient selection criteria differ significantly across this spectrum.
